Lost your password?

Target Group Inc. (OTCQB: CBDY) will soon expand the company’s cannabis seed growing operation in Ontario through wholly-owned subsidiary Canary Rx.

Today, Canary Rx announced a partnership with Dutch seed bank Serious Seeds B.V. to produce and distribute seeds. This exclusive global deal will cover all markets where cannabis seed and flower sales have been legalized.

Target Group added Canary Rx to the company’s stable of subsidiaries through the acquisition of all outstanding shares of Visava Inc. back in August. The Ontario-based Visava previously owned 100% of Canary Rx.

Serious Seeds is known for such award-winning strains as Bubble Gum, AK-47, Double Dutch, and Kali Mist. Those strains will be grown at Canary’s Norfolk County, Ontario facility, which is currently in the final stages of renovation.

Following demolition and internal structural upgrades, construction of the facility began in late 2017 and is expected to be completed next month. According to a press release from the company, Canary will produce 3,600 kg of cannabis product annually once construction is completed.

Simon Smit from Serious Seeds commented on the newly-announced partnership:

We’ve placed careful consideration into selecting an appropriate cannabis producer with which to share our genetics. Canary appealed to us because of their passionate, experienced growers, superior cultivation techniques, and our shared philosophy of quality over quantity. Serious Seeds has always been about breeding the best strains, not the most strains, and that will be our continued focus.

Canary Rx Chief Executive Officer Randall MacLeod also had this to say:

Selecting quality genetics is a fundamental aspect of producing premium cannabis, so we are delighted to be joining forces with such a distinguished and globally recognized breeder as Serious Seeds. This is just one strategic partnership for Canary as we position ourselves to become Canada’s preferred producer of premium cannabis products.

Canary Rx is currently in the final stage of the application process to become a licensed producer under the Access To Cannabis For Medical Purposes Regulations (ACMPR), and has stated its intention via Target Group to enter the recently-legalized recreational market.

Additional grow operations and partnerships with seed distributors have become a chief concern among publicly traded cannabis companies as chronic marijuana shortages affect the industry in the wake of nationwide legalization.

About Author

Ty Arthur

Ty Arthur

Ty Arthur has spent the last decade of his journalism career covering everything from cutting-edge tech to local news through outlets such as the Houston Chronicle. He has focused on the counterculture aspects of society, from marijuana legalization to underground music through Metalunderground.com and rapidly changing trends in the entertainment industry. He lives in the cold, dark north with his wife and son.

See author's posts

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.